Published in Cancer Weekly, December 3rd, 2002
Vesta Therapeutics is a portfolio company of Toucan Capital Corp., an investor in regenerative medicine. Vesta Therapeutics is developing therapies for repair and regeneration of liver and other major organs.
This divestiture will allow Incara Pharmaceuticals to focus on its catalytic antioxidant programs and reduce its operating expenses by approximately 40%. Net proceeds to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.